Dr. Espinosa founded ECommunity Research, LLC (ECR) in 2012 with the mission of performing the highest quality research.
Dr. Espinosa received his MD from Universidad Central del Ecuador in 2000. He was the recipient of a Fulbright Scholarship to complete a Masters’ Degree in Public Heath from Johns Hopkins University, Baltimore, MD in 2002. In 2003, he completed a post-doctoral fellowship in Dementia at the Alzheimer’s Disease Research Center at University of Kentucky followed by an internship and residency in Neurology at the University of Kentucky where he served as Chief Resident in the Department of Neurology. He completed a Fellowship in Neurophysiology, Epilepsy and Sleep Disorders at the Brigham and Women’s Hospital, Harvard Medical School, Boston, MA in 2008.
Dr. Espinosa has been Board Certified in Neurology by the American Board of Psychiatry and Neurology since 2009 and has been conducting clinical trials since 2001 at the University of Kentucky, Brigham and Women’s Hospital, and at North Oaks Hospital, LA.
Currently he is the Director of the Neurology Division of the Neurociescience Institute at North Oaks Hospital in Hammond, LA and founder of ECommunity Research, LLC.
Dr. Espinosa regularly authors scientific publications for medical journals and presents his research around the world. He serves on scientific editorial and advisory boards and performs peer reviews articles.
Dr. Yaira Garzon received her Medical degree from the Universidad Central del Ecuador in 2001. From 2002 to 2006 she acted as the Clinical Study Coordinator at the Neurology Department at the University of Kentucky where she became a Certified Clinical Research Coordinator. From 2002 to 2006 she was a Monitor for PAREXEL International, a Contract Research Organization (CRO). In 2009, she became the Manager/Clinical Study Coordinator at North Oaks Hospital for the Department of Neurology.
Dr. Garzon recently received her Master’s degree in Clinical Research Administration from The George Washington University in January 2012.
During her 10 years of experience in Clinical Research, Dr. Garzon has conducted or monitored studies for Abbot, AstraZeneca, Bayer, Chelsea Therapeutics, Cyberonics, EISAI, Elli Lilly, GlaxoSmithKline, Janssen, Novartis, Organon, Pfizer, Prostrakan, Renovo, Schwarz Pharma, Shire, Sunovion, Takeda Pharmaceutical, and UCB Pharma.